Waldenström's macroglobulinemia screening: Difference between revisions
No edit summary |
Sara Mohsin (talk | contribs) No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
According to the the | According to the the [[United States Preventive Services Task Force]] ([[United states preventive services task force recommendations scheme|USPSTF]]), there is insufficient [[evidence]] to recommend routine [[screening]] for [[lymphoplasmacytic lymphoma]]. | ||
==Screening== | ==Screening== | ||
According to the the | According to the the [[United States Preventive Services Task Force]] ([[USPSTF]]), there is insufficient [[evidence]] to recommend routine [[screening]] for [[lymphoplasmacytic lymphoma]].<ref name="US">Recommendations. US preventive services task force(2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=waldenstrom+macroglobulinemia Accessed on November 10, 2015</ref> | ||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Blood]] | [[Category:Blood]] | ||
[[Category:Hematology]] | [[Category:Hematology]] |
Revision as of 21:16, 29 July 2019
Waldenström's macroglobulinemia Microchapters |
Differentiating Waldenström's macroglobulinemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Waldenström's macroglobulinemia screening On the Web |
American Roentgen Ray Society Images of Waldenström's macroglobulinemia screening |
Directions to Hospitals Treating Waldenström's macroglobulinemia |
Risk calculators and risk factors for Waldenström's macroglobulinemia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2], Mirdula Sharma, MBBS [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]
Overview
According to the the United States Preventive Services Task Force (USPSTF), there is insufficient evidence to recommend routine screening for lymphoplasmacytic lymphoma.
Screening
According to the the United States Preventive Services Task Force (USPSTF), there is insufficient evidence to recommend routine screening for lymphoplasmacytic lymphoma.[1]
References
- ↑ Recommendations. US preventive services task force(2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=waldenstrom+macroglobulinemia Accessed on November 10, 2015